The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Refractory Status Epilepticus: Frequency, Risk Factors, and Impact on Outcome
Abstract
BACKGROUND: Refractory status epilepticus (RSE) is a life-threatening condition in which seizures do not respond to first- and second-line anticonvulsant drug therapy. How often RSE occurs, risk factors that predispose to this condition, and the effect of failure to control seizures on clinical outcome are poorly defined. OBJECTIVE: To determine the frequency, risk factors, and impact on outcome of RSE. DESIGN: Retrospective cohort study. SETTING: Large academic teaching hospital. PATIENTS: Consecutive sample of 83 episodes of status epilepticus in 74 patients (mean age, 63 years). MAIN OUTCOME MEASURES: Refractory status epilepticus was defined as seizures lasting longer than 60 minutes despite treatment with a benzodiazepine and an adequate loading dose of a standard intravenous anticonvulsant drug. Factors associated with RSE were identified using univariate and backward stepwiselogistic regression analyses. RESULTS: In 57 episodes (69%), seizures occurred after treatment with a benzodiazepine, and in 26 (31%), seizures occurred after treatment with a second-line anticonvulsant drug (usually phenytoin), fulfilling our criteria for RSE. Nonconvulsive SE (P=.03) and focal motor seizures at onset (P=.04) were identified as independent risk factors for RSE. Eleven (42%) of 26 patients with RSE had seizures after receiving a third-line agent (usually phenobarbital). Although mortality was not increased (17% overall), RSE was associated with prolonged hospital length of stay (P<.001) and more frequent functional deterioration at discharge (P=.02). CONCLUSIONS: Refractory status epilepticus occurs in approximately 30% of patients with SE and is associated with increased hospital length of stay and functional disability. Nonconvulsive SE and focal motor seizures at onset are risk factors for RSE. Randomized controlled trials are needed to define the optimal treatment of RSE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Comparison of Four Treatments for Generalized Convulsive Status Epilepticus
Treiman, D. M., Meyers, P. D., Walton, N. Y., Collins, J. F., Colling, C., Rowan, A. J., Handforth, A., Faught, E., Calabrese, V. P., Uthman, B. M., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809173391202 · Cited by 1,325
A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia
DeLorenzo, R. J., Hauser, W. A., Towne, A. R., Boggs, J. G., Pellock, J. M., Penberthy, L., Garnett, L., Fortner, C. A., & Ko, D. (1996) · Neurology · doi:10.1212/wnl.46.4.1029 · Cited by 1,060
Treiman, D. M. (1996) · PubMed · Cited by 1,024
Persistent Nonconvulsive Status Epilepticus After the Control of Convulsive Status Epilepticus
DeLorenzo, R. J., Waterhouse, E. J., Towne, A. R., Boggs, J. G., KO, D., DeLorenzo, G. A., Brown, A., & Garnett, L. (1998) · Epilepsia · doi:10.1111/j.1528-1157.1998.tb01177.x · Cited by 641
(1993) · JAMA · doi:10.1001/jama.270.7.854 · Cited by 477
Aminoff, M. J., & Simon, R. P. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90415-5 · Cited by 463
Status epilepticus at an urban public hospital in the 1980s
Lowenstein, D. H., & Alldredge, B. K. (1993) · Neurology · doi:10.1212/wnl.43.3_part_1.483 · Cited by 427
Comparison of Status Epilepticus with Prolonged Seizure Episodes Lasting from 10 to 29 Minutes
DeLorenzo, R. J., Garnett, L. K., Towne, A. R., Waterhouse, E. J., Boggs, J. G., Morton, L., Choudhry, M. A., Barnes, T., & Ko, D. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb02070.x · Cited by 250
Complex partial status epilepticus accompanied by serious morbidity and mortality
Krumholz, A., Sung, G. Y., Fisher, R. S., Barry, E., Bergey, G. K., & Grattan, L. M. (1995) · Neurology · doi:10.1212/wnl.45.8.1499 · Cited by 242
Treatment of Refractory Status Epilepticus with Propofol: Clinical and Pharmacokinetic Findings
Stecker, M. M., Kramer, T. H., Raps, E. C., O'Meeghan, R., Dulaney, E., & Skaar, D. J. (1998) · Epilepsia · doi:10.1111/j.1528-1157.1998.tb01269.x · Cited by 237
Propofol and Midazolam in the Treatment of Refractory Status Epilepticus
Prasad, A., Worrall, B. B., Bertram, E. H., & Bleck, T. P. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.27500.x · Cited by 223
Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus
Claassen, J., Hirsch, L. J., Emerson, R. G., Bates, J. E., Thompson, T. B., & Mayer, S. A. (2001) · Neurology · doi:10.1212/wnl.57.6.1036 · Cited by 220
Self-citationIntravenous valproate is well tolerated in unstable patients with status epilepticus
Sinha, S., & Naritoku, D. K. (2000) · Neurology · doi:10.1212/wnl.55.5.722 · Cited by 146
Gilbert, D. L., Gartside, P. S., & Glauser, T. A. (1999) · Journal of Child Neurology · doi:10.1177/088307389901400909 · Cited by 126
Waterhouse, E. J., Garnett, L. K., Towne, A. R., Morton, L. D., Barnes, T. Y., Ko, D., & DeLorenzo, R. J. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb00774.x · Cited by 112
Refractory status epilepticus in adults
Jagoda, A. S., & Riggio, S. (1993) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(05)80120-9 · Cited by 98
Advances in the management of refractory status epilepticus
Bleck, T. P. (1993) · Critical Care Medicine · doi:10.1097/00003246-199307000-00004 · Cited by 80
Generalized Convulsive Status Epilepticus
Cascino, G. D. (1996) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)64844-1 · Cited by 64
Use of midazolam in the treatment of refractory status epilepticus
Hanley, D. F., & Kross, J. F. (1998) · Clinical Therapeutics · doi:10.1016/s0149-2918(98)80106-9 · Cited by 47
Cited by
Guidelines for the Evaluation and Management of Status Epilepticus
Neurocritical Care Society Status Epilepticus Guideline Writing Committee, Brophy, G. M., Bell, R., Claassen, J., Alldredge, B., Bleck, T. P., Glauser, T., LaRoche, S. M., Riviello, J. J., Shutter, L., et al. (2012) · Neurocritical Care · doi:10.1007/s12028-012-9695-z · Cited by 1,623
Self-citationDetection of electrographic seizures with continuous EEG monitoring in critically ill patients
Claassen, J., Mayer, S. A., Kowalski, R. G., Emerson, R. G., & Hirsch, L. J. (2004) · Neurology · doi:10.1212/01.wnl.0000125184.88797.62 · Cited by 1,190
Self-citationShorvon, S., & Ferlisi, M. (2011) · Brain · doi:10.1093/brain/awr215 · Cited by 685
Claassen, J., Hirsch, L. J., Emerson, R. G., & Mayer, S. A. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.28501.x · Cited by 642
Self-citationBetjemann, J. P., & Lowenstein, D. H. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00042-3 · Cited by 495
Metadata
- Authors
- Mayer, S. A., Claassen, J., Lokin, J., Mendelsohn, F., Dennis, L. J., & Fitzsimmons, B.-F.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2002-02-01
- Volume
- 59
- Issue
- 2
- Pages
- 205
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W1988358928
- Cited by
- 658
- References
- 19
- FWCI
- 10.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.